|
ATP10D expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.685900E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.403400E-01 |
| Normal-vs-Stage2 |
4.609200E-01 |
| Normal-vs-Stage3 |
2.09190000000081E-05 |
| Normal-vs-Stage4 |
8.798100E-03 |
| Stage1-vs-Stage2 |
9.353800E-01 |
| Stage1-vs-Stage3 |
1.143960E-03 |
| Stage1-vs-Stage4 |
1.109810E-01 |
| Stage2-vs-Stage3 |
1.538220E-02 |
| Stage2-vs-Stage4 |
2.079800E-01 |
| Stage3-vs-Stage4 |
5.376800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.780200E-01 |
| Normal-vs-AfricanAmerican |
9.050400E-02 |
| Normal-vs-Asian |
5.871900E-02 |
| Caucasian-vs-AfricanAmerican |
5.974800E-01 |
| Caucasian-vs-Asian |
5.888000E-01 |
| AfricanAmerican-vs-Asian |
5.815400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.009780E-01 |
| Normal-vs-Female |
3.182800E-01 |
| Male-vs-Female |
7.910600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.672030E-01 |
| Normal-vs-Extreme_Weight |
2.624400E-01 |
| Normal-vs-Obese |
6.648400E-02 |
| Normal-vs-Extreme_Obese |
5.099600E-01 |
| Normal_Weight-vs-Extreme_Weight |
8.139800E-01 |
| Normal_Weight-vs-Obese |
8.543000E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.628000E-01 |
| Extreme_Weight-vs-Obese |
6.575400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
9.377000E-01 |
| Obese-vs-Extreme_Obese |
8.745400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.592000E-01 |
| Normal-vs-Age(41-60Yrs) |
4.476200E-01 |
| Normal-vs-Age(61-80Yrs) |
1.003450E-01 |
| Normal-vs-Age(81-100Yrs) |
3.66740000000698E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.687400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.957800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.605700E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.589600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.229100E-04 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.035600E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.198400E-01 |
| Normal-VS-Type2 PRCC |
3.908400E-02 |
| Normal-VS-KIRP CIMP |
4.239500E-04 |
| Normal-VS-Unclassified PRCC |
9.151000E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.445010E-01 |
| Type1 PRCC-VS-KIRP CIMP |
5.588200E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
6.244600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.647830E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.841400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.649730E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.216100E-04 |
| Normal-vs-N1 |
5.4633000001747E-07 |
| Normal-vs-N2 |
1.634790E-01 |
| N0-vs-N1 |
1.818390E-01 |
| N0-vs-N2 |
7.111600E-01 |
| N1-vs-N2 |
2.006800E-01 |
|
|
